dissecting microscope mounted with a spot insight digital camera (Diagnostic Instruments Inc)
90
Structured Review
Diagnostic Instruments Inc
dissecting microscope mounted with a spot insight digital camera
Dissecting Microscope Mounted With A Spot Insight Digital Camera, supplied by Diagnostic Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dissecting+microscope+mounted+with+a+spot+insight+digital+camera/dissecting+microscope+mounted+with+a+spot+insight+digital+camera/pm16985166-67-11-20
Average 90 stars, based on 1 article reviews
Dissecting Microscope Mounted With A Spot Insight Digital Camera, supplied by Diagnostic Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dissecting+microscope+mounted+with+a+spot+insight+digital+camera/dissecting+microscope+mounted+with+a+spot+insight+digital+camera/pm16985166-67-11-20
Average 90 stars, based on 1 article reviews
dissecting microscope mounted with a spot insight digital camera - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Microscopy:Article Title: Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. Article Snippet: We used pharmacological agents and genetic methods to determine whether the potent A3 adenosine receptor (AR) agonist 2-chloro-N-(3-iodobenzyl)adenosine-5 -N-methylcarboxamide (Cl-IB-MECA) protects against myocardial ischemia/ reperfusion injury in mice via the A3AR or via interactions with other AR subtypes.. Pretreating wild-type (WT) mice with Cl-IBMECA reduced myocardial infarct size induced by 30 min of coronary occlusion and 24 h of reperfusion at doses (30 and 100 g/kg) that concomitantly reduced blood pressure and stimulated systemic histamine release.. The A3AR-selective antagonist MRS 1523 [3-propyl-6-ethyl-5[(ethylthio)carbonyl]-2phenyl-4-propyl-3-pyridine-carboxylate], but not the A2AAR antagonist ZM 241385 [4-{2-7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl}phenol], blocked the reduction in infarct size provided by Cl-IB-MECA, suggesting a mechanism involving the A3AR. |